Pediatrix Medical Group, Inc.
US ˙ NYSE ˙ US58502B1061

SecurityMD / Pediatrix Medical Group, Inc.
InstitutionPacer Advisors, Inc.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Pacer Advisors, Inc. closes position in MD / Pediatrix Medical Group, Inc.

On May 6, 2026 - Pacer Advisors, Inc. filed a 13F-HR form disclosing ownership of 0 shares of Pediatrix Medical Group, Inc. (US:MD) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 24, 2026 disclosing 494,381 shares of Pediatrix Medical Group, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F Pediatrix Medical Group Common Stock - Domestic 58502B106 0 -100.00 0
2026-02-24 2025-12-31 13F/A-1 Pediatrix Medical Group Common Stock - Domestic 58502B106 494,381 -116,530 -19.07 10,575 3.34 0.0270
2025-10-15 2025-09-30 13F Pediatrix Medical Group Common Stock - Domestic 58502B106 610,911 -161,982 -20.96 10,233 -7.75 0.0258
2025-08-12 2025-06-30 13F Pediatrix Medical Group Common Stock - Domestic 58502B106 772,893 -220,055 -22.16 11,091 -22.91 0.0276
2025-05-06 2025-03-31 13F Pediatrix Medical Group Common Stock - Domestic 58502B106 992,948 -1,712,203 -63.29 14,388 -59.46 0.0337
2025-01-22 2024-12-31 13F Pediatrix Medical Group Common Stock - Domestic 58502B106 2,705,151 2,705,151 35,492 0.0766
2024-08-13 2024-06-30 13F Pediatrix Medical Group Common Stock - Domestic 58502B106 0 -5,228,815 -100.00 0 -100.00
2024-05-10 2024-03-31 13F Pediatrix Medical Group Common Stock - Domestic 58502B106 5,228,815 1,993,086 61.60 52,445 74.28 0.1206
2024-01-16 2023-12-31 13F PEDIATRIX MEDICAL GROUP Common Stock - Domestic 58502B106 3,235,729 1,809,828 126.93 30,092 66.04 0.0852
2023-11-13 2023-09-30 13F PEDIATRIX MEDICAL GROUP Common Stock - Domestic 58502B106 1,425,901 1,425,901 18,123 0.0694
2023-07-12 2023-06-30 13F PEDIATRIX MEDICAL GROUP Common Stock - Domestic 58502B106 0 -834,279 -100.00 0 -100.00
2023-05-02 2023-03-31 13F PEDIATRIX MEDICAL GROUP Common Stock - Domestic 58502B106 834,279 834,279 12,439 0.0531
2021-04-05 2021-03-31 13F MEDNAX Common Stock 58502B106 0 -38,161 -100.00 0 -100.00
2021-01-20 2020-12-31 13F MEDNAX Common Stock 58502B106 38,161 17,520 84.88 936 178.57 0.0176
2020-10-19 2020-09-30 13F MEDNAX Common Stock 58502B106 20,641 -223 -1.07 336 -5.88 0.0071
2020-07-29 2020-06-30 13F MEDNAX Common Stock 58502B106 20,864 -14,672 -41.29 357 -19.05 0.0072
2020-04-23 2020-03-31 13F MEDNAX Common Stock 58502B106 35,536 6,898 24.09 441 -44.60 0.0089
2020-02-10 2019-12-31 13F MEDNAX Common Stock 58502B106 28,638 -31,337 -52.25 796 -41.34 0.0360
2019-10-10 2019-09-30 13F MEDNAX Common Stock 58502B106 59,975 4,972 9.04 1,357 -2.23 0.0305
2019-08-12 2019-06-30 13F MEDNAX Common Stock 58502B106 55,003 55,003 1,388 0.0339
2019-02-13 2018-12-31 13F MEDNAX Common Stock 58502B106 0 -41,550 -100.00 0 -100.00
2018-11-14 2018-09-30 13F MEDNAX Common Stock 58502B106 41,550 8,782 26.80 1,939 36.65 0.0730
2018-08-14 2018-06-30 13F MEDNAX Common Stock 58502B106 32,768 4,953 17.81 1,419 -8.27 0.0642
2018-05-14 2018-03-31 13F MEDNAX COM 58502B106 27,815 3,979 16.69 1,547 21.43 0.0856
2018-02-14 2017-12-31 13F MEDNAX Com 58502B106 23,836 8,407 54.49 1,274 91.58 0.0894
2017-11-08 2017-09-30 13F MEDNAX Com 58502B106 15,429 13,489 695.31 665 468.38 0.0589
2017-08-08 2017-06-30 13F MEDNAX Com 58502B106 1,940 145 8.08 117 -6.40 0.0116
2017-05-09 2017-03-31 13F MEDNAX Com 58502B106 1,795 55 3.16 125 7.76 0.0153
2017-02-08 2016-12-31 13F MEDNAX Com 58502B106 1,740 -10 -0.57 116 0.00 0.0165
2016-11-10 2016-09-30 13F MEDNAX Com 58502B106 1,750 -10 -0.57 116 -8.66 0.0176
2016-08-12 2016-06-30 13F MEDNAX Com 58502B106 1,760 152 9.45 127 22.12 0.0201
2016-05-13 2016-03-31 13F MEDNAX Com 58502B106 1,608 68 4.42 104 -5.45 0.0236
2016-02-17 2015-12-31 13F MEDNAX Com 58502B106 1,540 1,540 110 0.0258
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.